Under construction – not a live service
Sign in
Taking peopleNo phase

Blood Pressure Screening in South African Children to Study High Blood Pressure

Screens children aged 5 to 18 for high blood pressure across South Africa.

Plain-language title generated from the registry record
Registry title: National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa

Key facts

Where
Zurich, SwitzerlandSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 5 and 18 years old?

Source: NCT05982847, who can take part

Where in Switzerland

  • University of ZurichZurich, SwitzerlandNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
North-West University, South Africa
Trial code
NCT05982847
Record updated
7 April 2026
Original description
The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.Read full original descriptionShow less

National Blood Pressure Screening in Children to Optimise Clinical Management of Paediatric Hypertension in South Africa

The Childhood Hypertension Consortium of South Africa (CHCSA) was established to foster relationships between the healthcare sector and schools through community engagement and outreach as well as contributing to the decolonization of normative paediatric blood pressure reference values. To date, there has been no nation-wide project in South Africa to determine nationally representative normal blood pressure reference values, nor to estimate the true prevalence of hypertension in the paediatric population of the country. This study will provide critical information on the understanding of blood pressure and hypertension in children, especially of African ancestry. Not only will this effort contribute to the development of the first nationally representative normal reference values of blood pressure but will also benefit healthcare providers in the sector with a clear guideline on the management of high blood pressure in children as developed by experts working with these challenges daily.

Inclusion: All children between ages 5-<18 years; All children with voluntary assent/consent and parent's permission.

Exclusion: randomly selected children who choose not to participate (lack of assent/consent), even if parent's permission was received,; Children will be excluded from the analysis for the determination of normative reference values for blood pressure and anthropometry if taking certain concomitant medication(s) that may affect their blood pressure, or any underlying disease e.g., chronic kidney disease, chronic heart disease etc. that may raise blood pressure; conditions that interfere with a patient's ability to follow study guidelines, e.g., the use of drugs, alcohol or tobacco products; ages >18 years or under 5 years; circumstances interfere with the participant's ability to give informed consent (diminished understanding or comprehension, or any language barriers that may pose potential risk in participation under false expectations).

ClinicalTrials.gov NCT05982847